Showing results (141-150 of 325) with videos related to

Sort By:
Pageof 33
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 6, 2022
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccinationNobumasa Okumura, Sho Saito, Yuki Takamatsu, et al.
Nucleosides, Nucleotides & Nucleic Acids|June 3, 2017
A novel entecavir analogue constructing with a spiro[2.4]heptane core structure in the aglycon moiety: Its synthesis and evaluation for anti-hepatitis B virus activityHiroki Kumamoto, Misato Fukano, Shuhei Imoto, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligandsArun K Ghosh, Gary Schiltz, Ramu Sridhar Perali, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2015
A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitroMasayuki Amano, Yasushi Tojo, Pedro Miguel Salcedo-Gómez, et al.
European Journal of Medicinal Chemistry|July 11, 2025
Design, synthesis, evaluation and X-ray structural studies of potent HIV-1 protease inhibitors containing substituted oxaspirocyclic carbamates as the P2 ligandsArun K Ghosh, Ryan Shaktah, Ajay K Ghosh, et al.
ACS Omega|September 22, 2025
SARS-CoV‑2 Main Protease Inhibitors Containing 5‑Substituted Benzothiazole-2-carbonyl Moieties at the P1' Site and Their DerivativesKohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variantsKazuhiko Ide, Manabu Aoki, Masayuki Amano, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2009
Synthesis and biological evaluation of novel allophenylnorstatine-based HIV-1 protease inhibitors incorporating high affinity P2-ligandsArun K Ghosh, Sandra Gemma, Elena Simoni, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300David A Davis, Haydar Bulut, Prabha Shrestha, et al.
Bioorganic & Medicinal Chemistry Letters|January 23, 2025
Potent HIV‑1 protease inhibitors containing oxabicyclo octanol-derived P2-ligands: Design, synthesis, and X‑ray structural studies of inhibitor-HIV-1 protease complexesArun K Ghosh, Monika Yadav, Ashish Sharma, et al.
Pageof 33